| Literature DB >> 20975968 |
Ts Tse1, Kf Cheng, Ks Wong, Ky Pang, Ck Wong.
Abstract
BACKGROUND: To review the complication rate of ventriculostomy-related infection in a local regional hospital, to identify risk factors of infections and suggest measures to prevent infections.Entities:
Keywords: External ventricular drain; ventriculitis prevention measures; ventriculostomy-related infections
Year: 2010 PMID: 20975968 PMCID: PMC2958322 DOI: 10.4103/2152-7806.69033
Source DB: PubMed Journal: Surg Neurol Int ISSN: 2152-7806
Figure 1Gender distribution
Gender
| Gender | No. of Case |
|---|---|
| Male | 190 |
| Female | 146 |
| Male: Female = 1.3:1 |
Figure 2Age distribution continuous
Figure 3Age distribution by group
Age
| Age | Years |
|---|---|
| Mean | 54.1 |
| Mode | 55 |
| Median | 55 |
| Oldest | 98 |
| Youngest | 1 day |
Figure 4Indication of ventriculostomy
Indications for EVD
| Indications for EVD | No. of cases | Percentage of total |
|---|---|---|
| Hemorrhage | 216 | 64.3 |
| Trauma | 53 | 15.8 |
| Tumor | 34 | 10.1 |
| Infection | 17 | 5.1 |
| Infarct | 13 | 3.9 |
| Hydrocephalus (causes other than any of the above mentioned) | 3 | 0.9 |
Figure 5Duration of ventriculostomy by episode
Figure 6Duration of ventriculostomy per catheter
Duration of EVD
| Duration of EVD | Days |
|---|---|
| Mean (per episode) | 7.39 (SD=6.10) |
| Mean (per EVD) | 6.93 (SD=5.11) |
| Mode (per EVD and per episode) | 3 |
| Median (per EVD and per episode) | 6 |
| Longest | 54 |
| Shortest | 0 |
Figure 7Manipulation of ventriclostomy
Manipulation
| Manipulation | No. of case | Percentage |
|---|---|---|
| Nil | 281 | 83.6 |
| Urokinase instillation | 42 | 12.5 |
| Amikicin irrigation | 7 | 2.0 |
| Frequent CSF sampling | 6 | 1.8 |
Figure 8Indication for revision of ventriculostomy
Figure 9Duration of ventriculostomy before revision
Indication for revision
| Indication for Revision | No. of cases | Percentage |
|---|---|---|
| Total no. of revised cases | 27 | 8 |
| Blockage of EVD | 18 | 5.3 |
| Bleeding | 4 | 1.1 |
| Suboptimal positioning of EVD | 3 | 0.9 |
| Hydrocephalus | 2 | 0.6 |
Duration of EVD before Revision
| Duration of EVD before Revision | Days |
|---|---|
| Mean | 6.2 |
| Median | 5 |
| Shortest | 0 |
| Longest | 31 |
Total Duration of EVD in revision cases
| Total Duration of EVD in revision cases | Days |
|---|---|
| Mean | 15.3 |
| Median | 14 |
| Shortest | 4 |
| Longest | 46 |
EVD tip culture
| EVD tip culture | No. of cases |
|---|---|
| No growth | 275 |
| Total positive EVD culture | 10 |
| Coagulase negative staphylococcus (other than epidermidis) | 5 |
| Bacillus | 3 |
| MSSA | 1 |
| Staphylococcus epidermidis | 1 |
Figure 10Ventriculostomy catheter tip culture
CSF culture
| CSF culture | No. of cases |
|---|---|
| No growth | 193 |
| Total CSF positive culture | 16 |
| Bacillus | 5 |
| Coagulase negative staphylococcus | 4 |
| MSSA | 2 |
| MRSA | 2 |
| MTB | 1 |
| 1 | |
| Klebsiella pneumoniae | 1 |
Figure 11Culture
Definition comparison
| Definition comparison | ||
|---|---|---|
| Consider Literature | Case of Ventriculostomy Infection according to considered literature (Infection rate) | Case of exclusion reason |
| Martinez and Mayhall | 12 (3.57) | 3 case did not have fever |
| Alan P. Lozier | 9 (2.68) | 6 cases of contamination (isolated culture positive with normal CSF glucose, protein and colour) |
| Harrop JS | 9 (2.68) | 6 cases had insolated culture postive (repeated CSF culture negative) |
| G K W Wong | 9 (2.68) | 3 cases had fever and positive culture but normal CSF cell count, glucose and protein. |
| 3 cases had positive culture but no fever and normal CSF cell count, glucose and protein. |
Figure 12Breakdown of culture positive cases
Figure 13Bacteria for culture positive cases
Duration of infection cases
| Duration of infection cases | Duration of EVD (days) |
|---|---|
| Mean | 9 |
| Standard deviation | ± 7.10 |
| Median | 6 |
| Shortest | 2 |
| Longest | 23 |
Ventriculostomy duration. (Infection vs no infection)
| Ventriculostomy duration. (Infection vs no infection) | No. of cases | Mean duration of EVD (days) | Standard deviation (days) |
|---|---|---|---|
| Infection | 10 | 9 | 7.1 |
| Overall | 336 | 7.39 | 6.1 |
Revision (Infection vs no infection)
| Revision (Infection vs no infection) | Revision | No revision | Total |
|---|---|---|---|
| Infection | 2 | 8 | 10 |
| No infection | 25 | 301 | 326 |
| Total | 27 | 309 | 336 |
| Percentage of infection | 7.4% | 2.59% |
Urokinase (Infection vs no infection)
| Urokinase (Infection vs no infection) | Urokinase | No urokinase | Total |
|---|---|---|---|
| Infection | 1 | 9 | 10 |
| No infection | 41 | 285 | 326 |
| Total | 42 | 294 | 336 |
| Percentage of infection | 2.38% | 3.06% |
Hemorrhage (Infection vs no infection)
| Hemorrhage (Infection vs no infection) | Hemorrhage as primary presentation | Hemorrhage not as primary presentation | Total |
|---|---|---|---|
| Infection | 7 | 3 | 10 |
| No infection | 209 | 117 | 326 |
| Total | 216 | 120 | 336 |
| Percentage of infection | 3.24 | 2.50 |
Multiple catheter (Infection vs no infection)
| Multiple catheter (Infection vs no infection) | Multiple catheter | Single catheter | Total |
|---|---|---|---|
| Infection | 1 | 9 | 326 |
| No infection | 4 | 322 | 326 |
| Total | 5 | 331 | 336 |
| Percent of infection | 20 | 2.72 |
Internation data compare
| Internation data compare | International composite[ | PYNEH |
|---|---|---|
| Culture positive | 463 | 23 |
| No. of patients | 5261 | 336 |
| No. of EVD | 5733 | 368 |
| Percentage of positive culture/patient | 8.8% (463/5261) | 6.8% (23/336) |
| Fisher’s Exact test | ||
| Percentage of positive culture/EVD | 8.08% | 6.25% (23/336) |
| Fisher exact test: |
Data comparison with consideration of clinical feature
| Series. | Patients | EVD | Positive culture | Rate per patient (%) | Rate per EVD (%) |
|---|---|---|---|---|---|
| Sundbarg | 540 | 540 | 54 | 10 | 10 |
| Mayhall | 172 | 213 | 19 | 11.05 | 8.92 |
| Schultz | 78 | 94 | 16 | 20.51 | 17.02 |
| Holloway | 584 | 712 | 61 | 10.45 | 8.57 |
| Lyke | 157 | 196 | 11 | 5.61 | 7.01 |
Sundbarg et al. classified positive CSF culture as a definite VRI if it was associated with CSF pleocytosis (defined as at least 11 leukocytes/mm3 with 50% or more polymorphonuclear neutrophils) and clinical symptoms that could not be attributed to causes other than ventriculitis. Several authors excluded patients with positive CSF cultures from the ventriculitis corhort on the ground that their infections were not primarily catheter related. The most widely accepted of such criteria required an initial sterile CSF culture obtained at the time of EVD insertion. Patients with positive CSF cultures at EVD insertion were diagnosed with preexisiting meningitis.
Compare international data
| CSF culture positive (rate/patient) | Simple size | Culture positive (pre-existing meningitis excluded) | Culture negative or pre-existing meningitis | % of positive culture (pre-existing meningitis excluded) | Fisher’s exact test (compared to data of this study) | Culture positive and correlated clinical and laboratory information | Not ventriculostomy related infection | % of infection with clinical correlation | Fisher’s exact test (compared to data of this study) |
|---|---|---|---|---|---|---|---|---|---|
| PYNEH (this study) | 336 | 15 | 321 | 4.46 | 10 | 326 | 2.98 | ||
| Mayhall | 172 | 19 | 153 | 11.05 | 0.0078 | ||||
| Schultz | 94 | 16 | 78 | 20.51 | 0.0001 | ||||
| Holloway | 584 | 61 | 523 | 10.45 | 0.0012 | ||||
| Lyke | 157 | 11 | 146 | 5.61 | 0.2798 | ||||
| Sundbarg | 540 | 54 | 486 | 10 | 0.0001 |
Practice recommendation
| Practice recommendation | Medical and operative management | Nursing care |
|---|---|---|
| Pre-operative and intra-operative | Peri-operative intravenous antibiotics Insertion of ventriculostomy only in the operative theatre Aseptic technique during entire operation with surgeons scrubbed and sterile gowned Scalp disinfected with 3 types of disinfectants (in sequel according to order of dis-infective power) before draped with sterile cloth If other neurosurgical procedures were performed in the same session, a separate skin incision and hole burr was used for insertion of EVD whenever possible Free drainage to room-air minimised upon immediate insertion of EVD to reduce pneumocephalus Percutanous tunnelling of at least 3cm before connection to external drainage system Catheter anchored to skin at site of percutanous tunnel exit | Patient’s head shaved for adequate exposure and reduce contamination from patient’s hair Aseptic technique during operative EVD insertion (nurse scrubbed and sterile gowned) with adequate sterile field. Sterile external drainage system assembled intra-operatively within the sterile field (by a gowned personal) The sterile ICP monitoring device was assemble in the external drainage system without direct contact with operative site External drainage system wrapped with anti-bacterial gel on sterile gauze and enclosed with water-proof material at all connection points Anti-septic gel applied to operative wound upon closure then dressed with sterile dressing |
| Post-operative (period which the catheter was in situ) | Post-operative care in ICU or HDU until ventriculostomy removed Patient monitored for symptoms or signs indicative of infection CSF and blood sampling at the slightest suspicion of infection Treatment of infection commenced when clinical features and laboratory test results suggest infection Revision of ventriculostomy NOT routinely performed unless clinically indicated Ventriculostomy removed as soon as the purpose of ventriculostomy had been fulfilled Ventriculostomy removal under strict aseptic technique and catheter tip routinely saved for bacterial culture | External drainage system maintained as a close system except during manipulation All manipulation of external drainage system keep to a minimal Aseptic technique (personal scrubbed and sterile gowned and establishment of a sterile field) when manipulation was required Sterile collection bag for CSF changed every once a week Upon manipulation of external drainage system CSF samplings from external system were performed |